Log in
Enquire now
‌

Cell Culture of Glioma Specimens for in Vitro Preclinical Studies

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT01125826
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT011258260
Health Conditions in Trial
Brain tumor
Brain tumor
0
Trial Recruitment Size
500
Trial Sponsor
Albany Medical College
Albany Medical College
0
Clinical Trial Start Date
2009
0
Primary Completion Date
2012
0
Study Completion Date
2012
0
Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Case-Only0
Observational Study Perspective
Prospective0
Participating Facility
Albany Medical Center
Albany Medical Center
0
Official Name
Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies0
Last Updated
June 27, 2011
0
Study summary

The purpose of this study is to culture primary human brain tumor cells with the specific aims of: 1. Develop primary cultures from human brain tumor surgical specimens 2. Determine the genetic and molecular fingerprints of brain tumors that may have prognostic significance 3. Delineate the mechanisms underlying oncogenesis of brain tumors. 4. Perform in vitro assays with brain tumor derived primary cultures to assess the efficacy of novel therapeutic agents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Cell Culture of Glioma Specimens for in Vitro Preclinical Studies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.